Search Results - "Lantry, Laura E"

Refine Results
  1. 1

    In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites by Linder, Karen E, Metcalfe, Edmund, Arunachalam, Thangavel, Chen, Jianqing, Eaton, Stephen M, Feng, Weiwei, Fan, Hong, Raju, Natarajan, Cagnolini, Aldo, Lantry, Laura E, Nunn, Adrian D, Swenson, Rolf E

    Published in Bioconjugate chemistry (17-06-2009)
    “…The metabolism of 177Lu-AMBA (AMBA = DO3A-CH2CO-G-(4-aminobenzoyl)-QWAVGHLM-NH2), a radiotherapeutic compound in clinical development that binds to GRP and NMB…”
    Get full text
    Journal Article
  2. 2

    Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA by Cagnolini, Aldo, Chen, Jianqing, Ramos, Kimberly, Skedzielewski, Tina Marie, Lantry, Laura E, Nunn, Adrian D, Swenson, Rolf E, Linder, Karen E

    Published in Applied radiation and isotopes (01-12-2010)
    “…Ga-AMBA (Ga-DO3A-CH(2)CO-G-[4-aminobenzoyl]-QWAVGHLM-NH(2)) is a bombesin-like agonist with high affinity for gastrin releasing peptide receptors (GRP-R)…”
    Get full text
    Journal Article
  3. 3

    In vitro binding evaluation of ¹⁷⁷Lu-AMBA, a novel ¹⁷⁷Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues by Thomas, Regi, Chen, Jianqing, Roudier, Martine M, Vessella, Robert L, Lantry, Laura E, Nunn, Adrian D

    “…Members of the gastrin-releasing peptide (GRP) family and its analogs bombesin (BBN) have been implicated in the biology of several human cancers including…”
    Get full text
    Journal Article
  4. 4

    A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin by Zhang, Z, Liu, Q, Lantry, L E, Wang, Y, Kelloff, G J, Anderson, M W, Wiseman, R W, Lubet, R A, You, M

    Published in Cancer research (Chicago, Ill.) (15-02-2000)
    “…Recent evidence indicates that individuals with a p53 germ-line mutation (Li-Fraumeni syndrome) have a 50% risk of developing lung cancer by age 60. In this…”
    Get full text
    Journal Article
  5. 5

    Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf by ZHONGQIU ZHANG, YIAN WANG, LANTRY, Laura E, KASTENS, Elizabeth, GONGJIE LIU, HAMILTON, Andrew D, SEBTI, Said M, LUBET, Ronald A, MING YOU

    Published in Oncogene (18-09-2003)
    “…Mutations in the Kras2 gene are seen in both human and mouse lung adenocarcinomas. The protein product (p21ras) encoded by the Kras2 gene must be…”
    Get full text
    Journal Article
  6. 6

    p53 Transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas by ZHONGQIU ZHANG, JIE LI, LANTRY, Laura E, YIAN WANG, WISEMAN, Roger W, LUBET, Ronald A, MING YOU

    Published in Cancer research (Chicago, Ill.) (01-06-2002)
    “…p53 Transgenic mice were crossed with C57BL/6J mice to investigate whether a germ-line mutation in the p53 gene predisposes for tumorigenesis in mice…”
    Get full text
    Journal Article
  7. 7

    Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Lantry, Laura E., Zhang, Zhongqiu, Yao, Rusheng, Crist, Keith A., Wang, Yian, Ohkanda, Junko, Hamilton, Andrew D., Sebti, Said M., lubet, Ronald A., You, Ming

    Published in Carcinogenesis (New York) (01-01-2000)
    “…The Ras protein undergoes a series of post-translational modifications at the C-terminal CAAX motif, which culminates with the anchoring of p21 Ras to the…”
    Get full text
    Journal Article
  8. 8

    CHEMOPREVENTIVE EFFICACY OF PROMISING FARNESYLTRANSFERASE INHIBITORS by Lantry, Laura E., Zhang, Zhongqiu, Crist, Keith A., Wang, Yian, Hara, Mitsunobu, Zeeck, Axel, Lubet, Ronald A., You, Ming

    Published in Experimental lung research (2000)
    “…The studies presented were designed to test the efficacy of farnesyltransferase inhibitors (FTIs) as potential chemopreventive compounds in the mouse lung…”
    Get full text
    Journal Article
  9. 9

    Cytotoxicity of tocopherols and their quinones in drug‐sensitive and multidrug‐resistant leukemia cells by Cornwell, David G., Jones, Kenneth H., Jiang, Zongcheng, Lantry, Laura E., Southwell‐Keely, Peter, Kohar, Indrajati, Thornton, Donald E.

    Published in Lipids (01-03-1998)
    “…Cytotoxicities of tocopherols (α‐T, γ‐T, δ‐T), their para (α‐TQ, γ‐TQ, δ‐TQ)‐and ortho (Tocored)‐quinone oxidation products, the synthetic quinone analog of…”
    Get full text
    Journal Article
  10. 10

    sup 177^Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression by Maddalena, Mary Ellen, Fox, Jaclyn, Chen, Jianqing, Feng, Weiwei, Cagnolini, Aldo, Linder, Karen E, Tweedle, Michael F, Nunn, Adrian D, Lantry, Laura E

    Published in The Journal of nuclear medicine (1978) (01-12-2009)
    “…^sup 177^Lu-DO3A-CH^sub 2^CO-G-4-aminobenzoyl-Q-W-A-V-G-H-L-M-NH^sub 2^ (^sup 177^Lu-AMBA) is a radiolabeled bombesin derivative that is bound and internalized…”
    Get full text
    Journal Article
  11. 11
  12. 12

    177Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression by Maddalena, Mary Ellen, Fox, Jaclyn, Chen, Jianqing, Feng, Weiwei, Cagnolini, Aldo, Linder, Karen E, Tweedle, Michael F, Nunn, Adrian D, Lantry, Laura E

    Published in The Journal of nuclear medicine (1978) (01-12-2009)
    “…(177)Lu-DO3A-CH(2)CO-G-4-aminobenzoyl-Q-W-A-V-G-H-L-M-NH(2) ((177)Lu-AMBA) is a radiolabeled bombesin derivative that is bound and internalized by cells…”
    Get full text
    Journal Article
  13. 13

    Automated synthesis, characterization and biological evaluation of [ 68Ga]Ga-AMBA, and the synthesis and characterization of natGa-AMBA and [ 67Ga]Ga-AMBA by Cagnolini, Aldo, Chen, Jianqing, Ramos, Kimberly, Marie Skedzielewski, Tina, Lantry, Laura E., Nunn, Adrian D., Swenson, Rolf E., Linder, Karen E.

    Published in Applied radiation and isotopes (01-12-2010)
    “…Ga-AMBA (Ga-DO3A-CH 2CO-G-[4-aminobenzoyl]-QWAVGHLM-NH 2) is a bombesin-like agonist with high affinity for gastrin releasing peptide receptors (GRP-R)…”
    Get full text
    Journal Article
  14. 14

    sup 177^Lu-AMBA: Synthesis and Characterization of a Selective ^sup 177^Lu-Labeled GRP-R Agonist for Systemic Radiotherapy of Prostate Cancer by Lantry, Laura E, Cappelletti, Enrico, Maddalena, Mary Ellen, Fox, Jaclyn S

    Published in The Journal of nuclear medicine (1978) (01-07-2006)
    “…Gastrin-releasing peptide receptors (GRP-R) are upregulated in many cancers, including prostate, breast, and lung. We describe a new radiolabeled bombesin…”
    Get full text
    Journal Article
  15. 15
  16. 16

    5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model by LANTRY, L. E, ZHANG, Z, CRIST, K. A, WANG, Y, KELLOFF, G. J, LUBET, R. A, YOU, M

    Published in Carcinogenesis (New York) (01-02-1999)
    “…Carcinogenesis is a multistep process in which many alterations in both genetic and epigenetic controls lead to a growth advantage for neoplastic cells…”
    Get full text
    Journal Article
  17. 17

    Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung by Lantry, Laura E., Zhang, Zhongqiu, Gao, Feng, Crist, Keith A., Wang, Yian, Kelloff, Gary J., Lubet, Ronald A., You, Ming

    Published in Journal of cellular biochemistry (1997)
    “…This study was designed to test the chemopreventive potential of perillyl alcohol, an inhibitor of farnesyltransferase, in a mouse lung tumor bioassay…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Ranibizumab, a mAb against VEGF-A for the potential treatment of age-related macular degeneration and other ocular complications by Lantry, Laura E

    Published in Current opinion in molecular therapeutics (01-12-2007)
    “…Genentech Inc and Novartis Ophthalmics AG have developed and launched the humanized anti-VEGF antibody fragment ranibizumab, a 48-kDa humanized antibody…”
    Get more information
    Journal Article
  20. 20

    Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesis by Herzog, Christopher R., Noh, Seong, Lantry, Laura E., Guan, Kuan-Liang, You, Ming

    Published in Molecular carcinogenesis (01-06-1999)
    “…The cyclin‐dependent kinase inhibitor 2a (Cdkn2a) locus encodes two distinct tumor suppressors, p16INK4a and p19ARF, whose functions interrelate in the…”
    Get full text
    Journal Article